Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitals

Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-ge...

Full description

Saved in:
Bibliographic Details
Published inArchives of toxicology Vol. 99; no. 8; pp. 3429 - 3441
Main Authors Ursini, C. L., Omodeo-Salè, E., Di Gennaro, G., Buresti, G., Fresegna, A. M., Ciervo, A., Gentile, M., Maiello, R., Beltramini, S., Gaggero, D., Rigamonti, N., Maccari, E., Zorzetto, G., Maiolino, P., Di Filippo, P., Bilancio, M. C., Baldo, P., Martinello, V., Di Mattia, A., Esposito, C., Nardulli, P., Laforgia, M., Cavallo, D.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2025
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity.
AbstractList Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity.Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity.
Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed workers. We established an Italian Network of seven Oncological Hospitals with the aim to evaluate, on a large size sample of workers, cyto-genotoxic effects by a sensitive and non-invasive biomarker also detecting workplace and personal contamination. We performed Buccal Micronucleus Cytome (BMCyt) assay on 200 workers handling ADs and 150 controls. AD contamination was detected performing workplace and personal monitoring of Gemcitabine, Ifosfamide, Cyclofosfamide and 5-Fluorouracil, using UHPLC MS/MS. We found in all the exposed group higher mean values of cells with micronucleus (MN‰), higher percentage of positivity to MN (subjects with micronucleated cells frequency exceeding a fixed cut-off value (1.5‰)), higher frequency of binucleated cells, broken eggs and total anomalies than in the controls. Taking into account the tasks (preparation, administration in Day Hospital and wards, administration in room operator and disposal), only preparators and administrators showed higher MN‰ frequency than in controls, whereas each task group showed a similar higher percentage of MN positives than in controls. We found low levels, but still detectable, of contamination in all the monitored workplaces. This study demonstrated induction of genotoxicity and of cytokinesis defect/arrest in buccal cells of workers handling antineoplastic drugs. The BMCyt assay was demonstrated to be a suitable biomarker of effect for biomonitoring of workers handling AD due to its high sensitivity and non-invasivity.
Author Omodeo-Salè, E.
Di Gennaro, G.
Di Filippo, P.
Bilancio, M. C.
Nardulli, P.
Martinello, V.
Baldo, P.
Gentile, M.
Fresegna, A. M.
Maccari, E.
Rigamonti, N.
Buresti, G.
Cavallo, D.
Maiello, R.
Di Mattia, A.
Beltramini, S.
Laforgia, M.
Gaggero, D.
Zorzetto, G.
Ursini, C. L.
Ciervo, A.
Esposito, C.
Maiolino, P.
Author_xml – sequence: 1
  givenname: C. L.
  orcidid: 0000-0003-3577-0331
  surname: Ursini
  fullname: Ursini, C. L.
  email: c.ursini@inail.it
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone
– sequence: 2
  givenname: E.
  surname: Omodeo-Salè
  fullname: Omodeo-Salè, E.
  organization: Hospital Pharmacy Department, European Institute of Oncology IRCCS
– sequence: 3
  givenname: G.
  surname: Di Gennaro
  fullname: Di Gennaro, G.
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone, Department of Public Health and Infectious Diseases, University of Rome “La Sapienza”
– sequence: 4
  givenname: G.
  surname: Buresti
  fullname: Buresti, G.
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone
– sequence: 5
  givenname: A. M.
  surname: Fresegna
  fullname: Fresegna, A. M.
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone
– sequence: 6
  givenname: A.
  surname: Ciervo
  fullname: Ciervo, A.
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone
– sequence: 7
  givenname: M.
  surname: Gentile
  fullname: Gentile, M.
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone
– sequence: 8
  givenname: R.
  surname: Maiello
  fullname: Maiello, R.
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone
– sequence: 9
  givenname: S.
  surname: Beltramini
  fullname: Beltramini, S.
  organization: Pharmacy Complex Unit, IRCCS Ospedale Policlinico San Martino
– sequence: 10
  givenname: D.
  surname: Gaggero
  fullname: Gaggero, D.
  organization: Pharmacy Complex Unit, IRCCS Ospedale Policlinico San Martino
– sequence: 11
  givenname: N.
  surname: Rigamonti
  fullname: Rigamonti, N.
  organization: Veneto Institute of Oncology IOV IRCCS
– sequence: 12
  givenname: E.
  surname: Maccari
  fullname: Maccari, E.
  organization: Veneto Institute of Oncology IOV IRCCS
– sequence: 13
  givenname: G.
  surname: Zorzetto
  fullname: Zorzetto, G.
  organization: Veneto Institute of Oncology IOV IRCCS
– sequence: 14
  givenname: P.
  surname: Maiolino
  fullname: Maiolino, P.
  organization: Hospital Pharmacy National Cancer Institute IRCCS Giovanni Pascale Naples
– sequence: 15
  givenname: P.
  surname: Di Filippo
  fullname: Di Filippo, P.
  organization: Hospital Pharmacy National Cancer Institute IRCCS Giovanni Pascale Naples
– sequence: 16
  givenname: M. C.
  surname: Bilancio
  fullname: Bilancio, M. C.
  organization: Hospital Pharmacy National Cancer Institute IRCCS Giovanni Pascale Naples
– sequence: 17
  givenname: P.
  surname: Baldo
  fullname: Baldo, P.
  organization: Hospital Pharmacy Unit, Centro Riferimento Oncologico CRO-Aviano – IRCCS, National Cancer Institute Aviano
– sequence: 18
  givenname: V.
  surname: Martinello
  fullname: Martinello, V.
  organization: Hospital Pharmacy Unit, Centro Riferimento Oncologico CRO-Aviano – IRCCS, National Cancer Institute Aviano
– sequence: 19
  givenname: A.
  surname: Di Mattia
  fullname: Di Mattia, A.
  organization: Hospital Pharmacy at the Campus Bio-Medico University Hospital Foundation in Rome
– sequence: 20
  givenname: C.
  surname: Esposito
  fullname: Esposito, C.
  organization: Hospital Pharmacy at the Campus Bio-Medico University Hospital Foundation in Rome
– sequence: 21
  givenname: P.
  surname: Nardulli
  fullname: Nardulli, P.
  organization: Pharmacy Unit, National Cancer Research Centre, “Giovanni Paolo II”
– sequence: 22
  givenname: M.
  surname: Laforgia
  fullname: Laforgia, M.
  organization: Pharmacy Unit, National Cancer Research Centre, “Giovanni Paolo II”
– sequence: 23
  givenname: D.
  surname: Cavallo
  fullname: Cavallo, D.
  organization: Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority–INAIL, Monte Porzio Catone
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40515820$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURC_wAiyQJTZsAr7E4wwbBBWXSpXYwNo645xkXBw72E7p8Kw8DM5MKZcFkqUjy9__-9xOqyMfPFbVY0afM0rVi0Qpp01NuaxpQ5Wo5b3qhDWC1-XSHlUnVDS0lmrFjqvTlK4oZbxdiwfVcUMlky2nJ9WPN7Mx4MhoTQx-Ng7nRMwuhxEJpAQ7kgPBa3AzZNw_1AP6kMONNQT7Hk1OJPQkGDNPkG3wxQxvppDmiIsWfLYew-Qg5SLp4jyklwSmyVmz50k5QBzEAUmCcXIl2O-4mH4L8QvGRPo5epu22JHNrhiSiwzOlugxL8j-f2-CC4NdatmGNNmCpIfV_b4EfHQbz6rP795-Ov9QX358f3H--rI2DW9zzQW0UrQNrJnqpVJSAZPdSlCxaVnXA6BY8b7bSNYzYLSclkIDquMtCsNW4qx6dfCd5s2InUGfIzg9RTtC3OkAVv_94u1WD-FaMy5Waq3WxeHZrUMMX2dMWY82GXQOSu_mpAVnrVJC8gV9-g96FUp_Sn2FalgZbbtP6cmfKd3l8mvyBeAHoMw9pYj9HcKoXtZLH9ZLl_XS-_XSsojEQZQK7AeMv__-j-onps_YuQ
Cites_doi 10.3390/ijerph20064952
10.1080/17435390.2022.214935
10.1177/1078155220907125
10.1016/j.ejso.2021.05.020
10.1016/j.mrrev.2011.06.005
10.1016/j.mrgentox.2005.07.008
10.1111/ijpp.12590
10.1007/s00204-023-03481-9
10.1093/mutage/gem032
10.1177/10781552221144303
10.56499/jppres16.107_4.3.122
10.1016/j.mrrev.2013.07.002
10.1016/j.toxlet.2018.05.031
10.1016/S1383-5718(98)00104-1
10.1007/s00420-023-01969-6
10.1016/j.toxlet.2019.08.022
10.3390/ijerph19148601
10.1080/17435390.2020.1850903
10.1016/s1383-5718(98)00180-6
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T2
7TK
7U7
C1K
K9.
7X8
5PM
DOI 10.1007/s00204-025-04073-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Health and Safety Science Abstracts (Full archive)
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)

MEDLINE

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1432-0738
EndPage 3441
ExternalDocumentID PMC12367979
40515820
10_1007_s00204_025_04073_5
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GrantInformation_xml – fundername: INAIL
  grantid: BRIC 2019 ID41
GroupedDBID ---
-Y2
.55
.86
.GJ
.HR
.VR
06C
06D
0R~
0VY
199
1N0
2.D
203
23N
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
4.4
406
408
409
40D
40E
4P2
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
7XC
88E
88I
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABRTQ
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACZOJ
ADBBV
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFGCZ
AFHIU
AFKRA
AFLOW
AFOHR
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ATCPS
ATHPR
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DWQXO
EBD
EBLON
EBS
EDH
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GQ8
GUQSH
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2O
M2P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
PATMY
PF0
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PT4
PT5
PYCSY
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RNI
RNS
ROL
RPX
RRX
RSU
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
X7M
YLTOR
Z45
ZGI
ZMTXR
ZOVNA
~EX
~KM
AAYXX
CITATION
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7T2
7TK
7U7
C1K
K9.
7X8
ALIPV
5PM
ID FETCH-LOGICAL-c428t-23a85384a917f57757a15d6303b81dfaae362fdb51f1a10a1080a4a7d28e3c163
IEDL.DBID C6C
ISSN 0340-5761
1432-0738
IngestDate Sat Aug 23 05:21:41 EDT 2025
Fri Jul 11 17:06:06 EDT 2025
Fri Aug 22 04:41:48 EDT 2025
Thu Aug 28 04:48:26 EDT 2025
Wed Aug 27 16:30:28 EDT 2025
Thu Aug 21 01:12:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Cytotoxicity
Antineoplastic drugs
Micronucleus
Genotoxicity
Buccal cells
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c428t-23a85384a917f57757a15d6303b81dfaae362fdb51f1a10a1080a4a7d28e3c163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-3577-0331
OpenAccessLink https://doi.org/10.1007/s00204-025-04073-5
PMID 40515820
PQID 3241405816
PQPubID 60277
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12367979
proquest_miscellaneous_3218773529
proquest_journals_3241405816
pubmed_primary_40515820
crossref_primary_10_1007_s00204_025_04073_5
springer_journals_10_1007_s00204_025_04073_5
PublicationCentury 2000
PublicationDate 20250800
PublicationDateYYYYMMDD 2025-08-01
PublicationDate_xml – month: 8
  year: 2025
  text: 20250800
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle Archives of toxicology
PublicationTitleAbbrev Arch Toxicol
PublicationTitleAlternate Arch Toxicol
PublicationYear 2025
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References M Palamini (4073_CR11) 2020; 26
C Delafoy (4073_CR7) 2023; 29
S Ndaw (4073_CR9) 2023; 20
C Sottani (4073_CR16) 2022; 19
S Burgaz (4073_CR3) 1999; 439
PV Rekhadevi (4073_CR12) 2007; 22
S Ndaw (4073_CR10) 2018; 298
HM Rodríguez-Montero (4073_CR13) 2016; 4
D Vanneste (4073_CR20) 2023; 97
S Bonassi (4073_CR2) 2011; 728
CL Ursini (4073_CR19) 2021; 15
CL Ursini (4073_CR18) 2019; 316
D Cavallo (4073_CR4) 2005; 587
F Roussin (4073_CR14) 2021; 47
N Titenko-Holland (4073_CR17) 1998; 417
H Huang (4073_CR8) 2023; 96
4073_CR6
C Bolognesi (4073_CR1) 2013; 753
D Cavallo (4073_CR5) 2022; 16
AN Santos (4073_CR15) 2020; 28
References_xml – volume: 20
  start-page: 4952
  year: 2023
  ident: 4073_CR9
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph20064952
– volume: 16
  start-page: 776
  year: 2022
  ident: 4073_CR5
  publication-title: Nanotoxicology
  doi: 10.1080/17435390.2022.214935
– volume: 26
  start-page: 1921
  year: 2020
  ident: 4073_CR11
  publication-title: J Oncol Pharm Pract
  doi: 10.1177/1078155220907125
– volume: 47
  start-page: 2939
  issue: 11
  year: 2021
  ident: 4073_CR14
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2021.05.020
– volume: 728
  start-page: 88
  issue: 2011
  year: 2011
  ident: 4073_CR2
  publication-title: Mutat Res
  doi: 10.1016/j.mrrev.2011.06.005
– volume: 587
  start-page: 45
  issue: 1–2
  year: 2005
  ident: 4073_CR4
  publication-title: Mutat Res
  doi: 10.1016/j.mrgentox.2005.07.008
– volume: 28
  start-page: 506
  year: 2020
  ident: 4073_CR15
  publication-title: Int J Pharmacy Practice
  doi: 10.1111/ijpp.12590
– volume: 97
  start-page: 1453
  issue: 6
  year: 2023
  ident: 4073_CR20
  publication-title: Arch Toxicol
  doi: 10.1007/s00204-023-03481-9
– volume: 22
  start-page: 395
  issue: 6
  year: 2007
  ident: 4073_CR12
  publication-title: Mutagenesis
  doi: 10.1093/mutage/gem032
– volume: 29
  start-page: 1628
  issue: 7
  year: 2023
  ident: 4073_CR7
  publication-title: J Oncol Pharm Pract
  doi: 10.1177/10781552221144303
– volume: 4
  start-page: 122
  issue: 3
  year: 2016
  ident: 4073_CR13
  publication-title: J Pharm & Pharmacogn Res
  doi: 10.56499/jppres16.107_4.3.122
– volume: 753
  start-page: 100
  issue: 2
  year: 2013
  ident: 4073_CR1
  publication-title: Mutat Res
  doi: 10.1016/j.mrrev.2013.07.002
– volume: 298
  start-page: 171
  year: 2018
  ident: 4073_CR10
  publication-title: Biomonitoring Surf Contam Toxicol Lett
  doi: 10.1016/j.toxlet.2018.05.031
– volume: 417
  start-page: 101
  year: 1998
  ident: 4073_CR17
  publication-title: Mutat Res
  doi: 10.1016/S1383-5718(98)00104-1
– volume: 96
  start-page: 785
  issue: 6
  year: 2023
  ident: 4073_CR8
  publication-title: Int Arch Occup Environ Health
  doi: 10.1007/s00420-023-01969-6
– ident: 4073_CR6
– volume: 316
  start-page: 20
  year: 2019
  ident: 4073_CR18
  publication-title: Toxicol Lett
  doi: 10.1016/j.toxlet.2019.08.022
– volume: 19
  start-page: 8601
  issue: 14
  year: 2022
  ident: 4073_CR16
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph19148601
– volume: 15
  start-page: 223
  issue: 2
  year: 2021
  ident: 4073_CR19
  publication-title: Nanotoxicology
  doi: 10.1080/17435390.2020.1850903
– volume: 439
  start-page: 97
  issue: 1
  year: 1999
  ident: 4073_CR3
  publication-title: Mutat Res
  doi: 10.1016/s1383-5718(98)00180-6
SSID ssj0012893
Score 2.4385624
Snippet Many antineoplastic drugs (ADs) used to treat cancer are characterized by the non-selective effect representing a possible cause of health effects in exposed...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3429
SubjectTerms 5-Fluorouracil
Adult
Antineoplastic Agents - adverse effects
Antineoplastic Agents - analysis
Antineoplastic Agents - toxicity
Antineoplastic drugs
Apoptosis
Assaying
Biological Monitoring - methods
Biomarkers
Biomedical and Life Sciences
Biomedicine
Biomonitoring
Cell growth
Chemotherapy
Chromatography
Contamination
Cytokinesis
Deoxycytidine - analogs & derivatives
DNA Damage
Drugs
Environmental Health
Environmental Monitoring - methods
Environmental research
Exposure
Female
Fluorouracil
Gemcitabine
Genotoxicity
Genotoxicity and Carcinogenicity
Hospitals
Humans
Ifosfamide
Italy
Laboratories
Male
Medical personnel
Micronucleus Tests - methods
Middle Aged
Mouth Mucosa - drug effects
Mouth Mucosa - pathology
Occupational exposure
Occupational Exposure - adverse effects
Occupational Exposure - analysis
Occupational health
Occupational Medicine/Industrial Medicine
Pharmacology/Toxicology
Pollution control
Workplaces
Title Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitals
URI https://link.springer.com/article/10.1007/s00204-025-04073-5
https://www.ncbi.nlm.nih.gov/pubmed/40515820
https://www.proquest.com/docview/3241405816
https://www.proquest.com/docview/3218773529
https://pubmed.ncbi.nlm.nih.gov/PMC12367979
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9NAEF1Be0FCiG8MpRokbmAp3vV6HW5J1FBA9ESkcrL2y7RSa1e1LTX8Vn4MM2vHNC0ckKLksJtx7JnNvt15-4axt5lJrJYYvJxbRSXMXDz1ExNPvPLSCitcSfsdX4-yw1X6-VgeDzI5dBbmRv6exD458SS4jDHclIjlXbYrE6GoTMMiW4wZA1w49KWQ00mMGDoZDsj83cb2JHQLWd4mSN7IkobJZ_mQPRhQI8x6Nz9id3z1mN3vt9ygP0n0hP2ad_igzuCcOHYV6RR3Ddh1W597QIis19DWMKh7-9AQk0JrW1-hkYHXAXUJ9TXhYfBXFzVtItJ3NVWVIMa5JnFncJfdj-YDXEuBA740nBG5HBpNusPQnP70ZJT4X4g0ocQ7IRq-A7NGg_CpDRstUPV09HD9ym7-keFkKGvSPGWr5cG3xWE8FG-ILa5o2pgLjUggTzWuB0uplFQ6kS7DGdMgRC619jh1ls7IpEx0MtHEddSpVo7nXlhEic_YTlVX_gUDLgSCUp4JJ31qhDEyLbVxwnmL8DP3EXu38WZx0Wt0FKMac_B9gb4vgu8LGbG9jcOLYbw2BcJKXGnKPMki9mZsxpFG6RONj7ajPkmuFALWacSe9_ExXi6lUjkIpiKWb0XO2IFUvLdbqtOToOYdNPSmCo2-3wTZn9_179t4-X_dX7F7PAwAoi7usZ32svOvEU61Zp_tzpbz-RF9fvz-5WA_jCt8X_HZb482IMY
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagHEBCiDcpBQaJG1jaxHGc5VYQ1RbanrpSb5FfaSu1SdUkUpff2h_DjPOgS-GAtDc7ziYzjj97vvmGsQ-Zia2W6LxJYhWVMHN87meGz7zy0gorXEnnHfsH2WKZfj-SR0NSWDOy3ceQZPhST8luIY-TU_lVdDwluLzL7iEYyMmXl8n2FDvALURfFDmdcUTT8ZAq8_cx1pejWxjzNlXyj3hpWIZ2HrNHA36E7d7gT9gdXz1lD_vDN-hzip6x6y8dvrIzOCe2XUWKxV0DdtXW5x4QLOsVtDUMOt8-NHDSam3rKxxkYHhAXUJ9Q4IY_NVFTceJdK2m-hLEPdck8wzusjtuPsONYDjgT8MZ0cyh0aRADM3pT0-DEhMMMSeU-CREyHdgVjgg7LbhyAWqnpge7l_Z8dsMJ0OBk-Y5W-58O_y64EMZB25xb9PyRGjEBHmqcWdYSqWk0rF0Ga6dBsFyqbXHRbR0RsZlrOOZJtajTrVySe6FRbz4gm1UdeVfMUiEQHiaZMJJnxphjExLbZxw3iIQzX3EPo7WLC56tY5i0mUOti_Q9kWwfSEjtjUavBhmblMgwMQ9p8zjLGLvp2accxRI0fhqO-oT50ohdJ1H7GXvH9PtUiqag7AqYvma50wdSM97vaU6PQm63kFNb65w0E-jk_3-X_9-jM3_6_6O3V8c7u8Ve7sHP16zB0mYDERo3GIb7WXn3yDIas3bMKd-AZZyI-Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSAgJVeWdUmCQuEHUdRzH2d7ahVXLo-JApd4iO3ZopTZZNYnU5bfyY5hxHuxSOCDlZu_kMeP1Z_ubbxh7kxiea4nBG0W5ohJmNpy6iQknTjmZi1zYgvY7vhwnhyfxx1N5upLF79nuw5Fkl9NAKk1ls7uwxe6Y-OZzOkMqxYpBqEQob7M7uFLhtPyaJbPxHAGXE12B5HgSIrLmfdrM322sT0038OZN2uQfZ6d-Sppvsc0eS8J-5_wH7JYrH7L73UYcdPlFj9jPgxY_3wVcEvOuJPXitoZ82VSXDhA46yU0FfSa3843hKTb2lTXaKRne0BVQLUiRwzuelHR1iL9VlOtCeKha5J8BnvVfq_3YOVgHPDScEGUc6g1qRFDff7DkVFihSH-hALfhMj5FswSDcJR47dfoOxI6v7-ZT78T8NZX-ykfsxO5h--zQ7DvqRDmOM6pwkjoREfpLFGVxVSKak0lzbBedQgcC60djihFtZIXnDNJ5oYkDrWykapEzlixydso6xK94xBJARC1SgRVrrYCGNkXGhjhXU5gtLUBezt4M1s0Sl3ZKNGs_d9hr7PvO8zGbCdweFZP4rrDMEmrj9lypOAvR6bcfzRoYrGT9tSH54qhTB2GrCnXXyMt4upgA5CrICla5EzdiBt7_WW8vzMa3x7Zb2pQqPvhiD7_Vz_fo3t_-v-it39-n6efT46_vSc3Yv8WCBu4w7baK5a9wLxVmNe-iH1C3qPKAo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Buccal+micronucleus+cytome+assay+to+evaluate+cyto-genotoxic+effects+of+occupational+exposure+to+antineoplastic+drugs%3A+application+on+a+large+sample+size+of+workers+furnished+by+an+Italian+network+of+oncological+hospitals&rft.jtitle=Archives+of+toxicology&rft.au=Ursini%2C+C.+L&rft.au=Omodeo-Sal%C3%A8%2C+E&rft.au=Di+Gennaro%2C+G&rft.au=Buresti%2C+G&rft.date=2025-08-01&rft.pub=Springer+Nature+B.V&rft.issn=0340-5761&rft.eissn=1432-0738&rft.volume=99&rft.issue=8&rft.spage=3429&rft.epage=3441&rft_id=info:doi/10.1007%2Fs00204-025-04073-5&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-5761&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-5761&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-5761&client=summon